Chart of the Day: IPOs Are Exciting if You Already Own a Piece
SuRo is an investor in one of the big three upcoming IPOs, but it’s not SpaceX.
These Biopharma Names Don’t Have the Flash of SpaceX, but They’re Reliable
Here are four biotech plays that should stand up if the market starts to break down.
Spotlight Shines on a SuRo Capital Position…And It’s Not the One You Think
It’s not OpenAI, nor is it affiliated with Nvidia.
Why I Am Buying This Specialty Drug Stock
There is a relief bounce on an in-line CPI report, but the inflation issue isn’t going away.
Cracker Barrel Is a Dumpster Fire After Rebranding Embarrassment
The casual dining chain has a brutal balance sheet.
May CPI Up Largely as Expected, But It’s Not That Simple
Ahead of tomorrow’s U.S. May PPI report, China’s May PPI accelerated further.
Tech Investors Must Watch This Key Indicator
Investors are eager to know when the SaaSpocolypse will end.
May CPI, End to Ceasefire?: 8 Key Items Shaping the Stock Market Wednesday
TSM’s May revenue, SpaceX’s oversubscription, bank stress tests, and other headlines are moving stocks this morning.
A Downed Copter, Sinking Sentiment, and a Giant IPO Called SpaceX
Let’s look at how market sentiment on thin ice can absorb a failing ceasefire and a mega-IPO. Also, put Saronic on your radar.
Stagflation Worries Take Center Stage as CPI Looms
This tricky market environment requires a stout defense.